"nirsevimab" meaning in All languages combined

See nirsevimab on Wiktionary

Noun [English]

Etymology: From [Term?] + -vi- + -mab. Etymology templates: {{af|en||-vi-|-mab}} [Term?] + -vi- + -mab Head templates: {{en-noun|-}} nirsevimab (uncountable)
  1. (pharmacology) A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants. Tags: uncountable Categories (topical): Pharmaceutical drugs
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-vi-",
        "4": "-mab"
      },
      "expansion": "[Term?] + -vi- + -mab",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -vi- + -mab.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nirsevimab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -vi-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -mab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2023 May 18, Christina Jewett, “F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants”, in The New York Times:",
          "text": "There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter or in the fall, Jonathan Heinrichs, a Sanofi executive said in an interview.",
          "type": "quote"
        }
      ],
      "glosses": [
        "A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants."
      ],
      "id": "en-nirsevimab-en-noun-7acIPzDS",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "prevent",
          "prevent"
        ],
        [
          "respiratory syncytial virus",
          "respiratory syncytial virus"
        ],
        [
          "RSV",
          "RSV"
        ],
        [
          "infection",
          "infection"
        ],
        [
          "infant",
          "infant"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "nirsevimab"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "",
        "3": "-vi-",
        "4": "-mab"
      },
      "expansion": "[Term?] + -vi- + -mab",
      "name": "af"
    }
  ],
  "etymology_text": "From [Term?] + -vi- + -mab.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "nirsevimab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English term requests",
        "English terms interfixed with -vi-",
        "English terms suffixed with -mab",
        "English terms with quotations",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2023 May 18, Christina Jewett, “F.D.A. Panel Recommends R.S.V. Vaccine to Protect Young Infants”, in The New York Times:",
          "text": "There is another remedy under regulatory consideration, a monoclonal antibody shot developed by Sanofi and AstraZeneca, called nirsevimab. It is meant to be given at the hospital to babies who are born during the winter or in the fall, Jonathan Heinrichs, a Sanofi executive said in an interview.",
          "type": "quote"
        }
      ],
      "glosses": [
        "A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "human",
          "human"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ],
        [
          "prevent",
          "prevent"
        ],
        [
          "respiratory syncytial virus",
          "respiratory syncytial virus"
        ],
        [
          "RSV",
          "RSV"
        ],
        [
          "infection",
          "infection"
        ],
        [
          "infant",
          "infant"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A human recombinant monoclonal antibody used to prevent respiratory syncytial virus (RSV) infections in infants."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "nirsevimab"
}

Download raw JSONL data for nirsevimab meaning in All languages combined (1.8kB)


This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-11-06 from the enwiktionary dump dated 2024-10-02 using wiktextract (fbeafe8 and 7f03c9b). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.